Profile
Lijun Sun was the founder of Silicon INSITE, Inc. (founded in 2016) where he held the title of Director & Head-Discovery.
He previously worked as a Senior Director-Chemistry at Shionogi Bioresearch Corp.
from 1997 to 2002.
From 2009 to 2016, he was the Vice President-Chemistry at Synta Pharmaceuticals Corp.
He also served as an Independent Non-Executive Director at TOT BIOPHARM International Co. Ltd.
from 2019 to 2022.
Dr. Sun was a Director-Drug Discovery Center at Beth Israel Deaconess Medical Center, Inc. and an Associate Professor at Harvard Medical School.
Dr. Sun received his doctorate degree from Emory University in 1996 and his graduate degree from Georgetown University in 1992.
Former positions of Lijun Sun
| Companies | Position | End |
|---|---|---|
| TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Director/Board Member | 2022-03-11 |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 2016-07-25 |
| Shionogi Bioresearch Corp. | Corporate Officer/Principal | 2001-12-31 |
| Harvard Medical School | Corporate Officer/Principal | - |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Training of Lijun Sun
| Emory University | Doctorate Degree |
| Georgetown University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
| Shionogi Bioresearch Corp. | |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Lijun Sun
